Protandim for Health & Longevity - Quick Reference Sheet

Protandim for Health & Longevity

Created on 07/18/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Protandim is a five-plant supplement meant to prompt the body to make its own protective enzymes. The idea is plausible, and one animal study found longer life in male mice, but human evidence is thin, inconsistent, and often tied to its makers. It is generally well tolerated, though two ingredients carry rare liver concerns; long-term benefit in people remains unproven. (Full Review)

Protocol

Standard Dose
675 mg
One caplet, once daily
Best Time
With food
Aids absorption of fat-soluble curcumin
Dose Escalation
Not advised
No evidence splitting or higher doses improve response
Time to effect
Oxidative markers
~30 days
Early drop in oxidative-damage markers, when seen
Antioxidant enzymes
~120 days
Rise in the body's own protective enzymes
Subjective effects
Often none
Any effect is gradual, not immediately perceptible

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Active or prior cancer
  • Liver disease or elevated liver enzymes (ALT/AST above ~2× upper limit)
  • Hyperthyroidism or autoimmune thyroid disease
  • Scheduled surgery (stop 1–2 weeks before)
Key Interactions
  • Narrow-margin CYP3A4/P-glycoprotein drugs (simvastatin, tacrolimus, cyclosporine, warfarin)
  • High-dose acetaminophen
  • Other green tea extract or high-dose curcumin supplements
  • Other antioxidant or Nrf2-activating supplements (sulforaphane, alpha-lipoic acid, high-dose vitamin C and E)
  • High antioxidant intake around exercise training

Risk & Side Effects

  • Low: Gastrointestinal discomfort, idiosyncratic liver injury from botanical components
  • Speculative: Pro-tumorigenic effects of sustained Nrf2 activation, herb–drug metabolism interactions, ashwagandha-related endocrine and immune effects

Monitoring

Marker Target Why
ALT / AST ALT ~10–25 U/L; AST ~10–25 U/L Detect rare botanical liver injury
GGT < 20 U/L Sensitive liver and oxidative-stress marker
hs-CRP < 1.0 mg/L (ideally < 0.5) Tracks systemic inflammation
F2-isoprostanes (urine) Low relative to lab reference Most reliable direct marker of oxidative stress
TSH 0.5–2.5 mIU/L Screens for ashwagandha-driven thyroid over-activation
HbA1c < 5.4% Baseline metabolic context relevant to oxidative burden

Cadence: Baseline, then at 8–12 weeks, then every 6–12 months (liver testing prioritized)

Qualitative Assessment

  • Perceived energy and daytime fatigue
  • Exercise recovery and perceived exertion
  • Sleep quality
  • General sense of well-being